pharma · DCOY
Decoy Therapeutics
Decoy Therapeutics patent portfolio — 6 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- HOUSTON, TX, USA
- Programs
- 0
- Drugs
- 0
- Patents
- 6
Decoy Therapeutics patents
6 pharmaceutical patents indexed for Decoy Therapeutics. 0 expire within 24 months.
Decoy Therapeutics has 6 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12226474
Methods and compositions for treating infections
granted -
US 11147844
Methods of treatment of infections using bacteria
granted -
US 11045504
Compositions and methods for treatment of cancer using bacteria
granted -
US 10195259
Compositions and methods for treatment of cancer using bacteria
granted -
US 10052371
Compositions and methods for treatment of cancer using bacteria
granted -
US 9265804
Compositions and methods for treatment of cancer using bacteria
granted
Frequently asked questions
How many patents does Decoy Therapeutics have?
6 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Decoy Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.